These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9718175)

  • 1. Pure mucinous carcinoma of the breast: a clinicopathologic correlation study.
    Avisar E; Khan MA; Axelrod D; Oza K
    Ann Surg Oncol; 1998; 5(5):447-51. PubMed ID: 9718175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
    White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
    J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancer.
    Noguchi M; Ohta N; Koyasaki N; Taniya T; Miyazaki I; Mizukami Y
    Cancer; 1991 Nov; 68(9):1918-25. PubMed ID: 1655229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age and Receptor Status Do Not Indicate the Need for Axillary Dissection in Patients with Sentinel Lymph Node Metastases.
    Mamtani A; Patil S; Van Zee KJ; Cody HS; Pilewskie M; Barrio AV; Heerdt AS; Morrow M
    Ann Surg Oncol; 2016 Oct; 23(11):3481-3486. PubMed ID: 27169771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes.
    Veronesi U; Cascinelli N; Greco M; Bufalino R; Morabito A; Galluzzo D; Conti R; De Lellis R; Delle Donne V; Piotti P
    Ann Surg; 1985 Dec; 202(6):702-7. PubMed ID: 3000303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoechoic axillary lymph node metastases of mucinous carcinoma of the breast: a case report.
    Kamitani K; Ono M; Toyoshima S; Mitsuyama S; Anan K; Ikeda Y
    Breast Cancer; 2006; 13(4):382-5. PubMed ID: 17146168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinicopathologic features of micropapillary variant of pure mucinous carcinoma of breast].
    Lin HY; Gao LX; Jin ML; Ding HY
    Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):613-7. PubMed ID: 23157830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for regional nodal failure after breast-conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes.
    Grills IS; Kestin LL; Goldstein N; Mitchell C; Martinez A; Ingold J; Vicini FA
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):658-70. PubMed ID: 12788171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of conservative therapy for invasive breast cancer by histologic subtype.
    Weiss MC; Fowble BL; Solin LJ; Yeh IT; Schultz DJ
    Int J Radiat Oncol Biol Phys; 1992; 23(5):941-7. PubMed ID: 1322387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
    Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
    J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of pure mucinous breast carcinoma compared to infiltrating ductal carcinoma: a population-based study from China.
    Cao AY; He M; Liu ZB; Di GH; Wu J; Lu JS; Liu GY; Shen ZZ; Shao ZM
    Ann Surg Oncol; 2012 Sep; 19(9):3019-27. PubMed ID: 22451233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracapsular extension in positive axillary lymph nodes in female breast cancer patients. Patterns of failure and indications for postoperative locoregional irradiation.
    Stranzl H; Mayer R; Ofner P; Peintinger F; Prettenhofer U; Hackl A
    Strahlenther Onkol; 2004 Jan; 180(1):31-7. PubMed ID: 14704842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pure mucinous carcinoma of the breast: is axillary staging necessary?
    Paramo JC; Wilson C; Velarde D; Giraldo J; Poppiti RJ; Mesko TW
    Ann Surg Oncol; 2002 Mar; 9(2):161-4. PubMed ID: 11888873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do clinical and immunohistochemical findings of pure mucinous breast carcinoma differ from mixed mucinous breast carcinoma?
    Erhan Y; Ciris M; Zekioglu O; Erhan Y; Kapkac M; Makay O; Ozdemir N
    Acta Chir Belg; 2009; 109(2):204-8. PubMed ID: 19499682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic features predicting involvement of non- sentinel axillary lymph nodes in Iranian women with breast cancer.
    Moosavi SA; Abdirad A; Omranipour R; Hadji M; Razavi AE; Najafi M
    Asian Pac J Cancer Prev; 2014; 15(17):7049-54. PubMed ID: 25227789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.
    Kiluk JV; Ly QP; Santillan AA; Meade T; Ramos D; Reintgen DS; Dessureault S; Davis M; Shamehdi C; Cox CE
    Ann Surg Oncol; 2010 Feb; 17(2):552-7. PubMed ID: 19957043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the tracing effect of carbon nanoparticle and carbon nanoparticle-epirubicin suspension in axillary lymph node dissection for breast cancer treatment.
    Du J; Zhang Y; Ming J; Liu J; Zhong L; Liang Q; Fan L; Jiang J
    World J Surg Oncol; 2016 Jun; 14(1):164. PubMed ID: 27335011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.